Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
31
2022

Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales BOCA RATON, Fla, Jan. 31, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly…

January
26
2022

Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022

BOCA RATON, Fla, Jan. 26, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

January
10
2022

Keloid Scar Removal Near Me: What is It?

Keloids are a mystery for most people. The average person doesn’t know what they are and why they exist. It’s estimated that 10% of people have at least one keloid. Some keloids are small and…

January
06
2022

Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference

Company Management Available for 1×1 Meetings Concurrent with the 40th Annual J.P. Morgan Healthcare Conference January 10-14 BOCA RATON, Fla. , Jan. 06, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy